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Arachidonic acid and its metabolites (eicosanoids) are mem-
brane-derived inflammatory mediators with a diverse set of 
biologic propercies affecting numerOUS cells and organ sys-
[ems, incl uding [be skin. They have been implicated in [he 
pathogenesis of inflammatory skin disease and post-inflam-
macory hyperpi gmencacion. W e have scudied [he ability of 
arachidonic acid, prostaglandin D2 • prostaglandin E2 • leuko-
tricne B. ! leukocriene C .. , leukotriene 0 .. . and leukorriene E", 
to enhance the growth of cultured human melanocytes. Of 
th ese compounds. only leukotriene C .. and leukotriene D4 
H uman rnelanocytes grow poorly in culture unless stimulated by se rum and mitogens [t]. These mito-gens can be classified into three groups based on potency and chemical structure: tumor promoters (phorbol esters), cyclic AMP stimulants (cholera 
toxin, isobutylmethylxanthine. dibutyryl cycl ic AMP, alpha-mela-
nocyte srimulating hormone). and peptide growth factors (basic 
fibroblast growth [accor, bFGF) [1- 5J. Of these. bFGF and alpha-
MSH are the only natur.ally produced melanocyte mitogens [4,5] . 
Botb these substances require the 2ssisunce of other mitogens to 
promote mel2nocyte growth. bFGF requires a cycl ic AMP stimu-
lant [4]. and alpha-MSH requires a tumor promoter !5). BeC2use the 
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AA: arachidonic acid 
Alpha-MSH: alpha melanocyte stimulating honnone 
AMP: ade nosine Illonophosphatc 
bFGF: basic fibroblast growth factor 
BPE; bovine pituitary extraci 
DNA: dcoxynucleic acid 
EGF: epidermal growth factor 
HPLC: high pC'rforma.nce liquid ch romatography 
lBMX: isoburylmethylxan thine 
IPJ : inositol trisphosph:n e 
KGM : ker.ltinocyte growth med ia 
LT13. : lcukotriene D. 
LTC.: Icukotriene C. 
LTD.: Icukotricne 0, 
L TE,: Icukotricnc E, 
PGD2: prostagl andi n D2 
PG~: prostagla.ndin E.z 
PI : phosphatidyl inositol 
TPA: o~tetradccanoylphorbol 1 3~acetare 
U VB: ultraviolet n 
were capable of stimulating melanocyu· proliferation. In ad-
dition. cultured melanocytes metabolized leukotriene Co( to 
ieukotriene Eo( with greater than 60% conversion in less than 
three hours. Melanocytes grown on suboptimal media (dou-
bling time 12 - 20 days) respond in a dose-dependent fashion 
to leukorriene C .. , with a significant difference from control 
nmed at 28 days with a concentration of LTC. of30 nM and a 
doubling time of 5 - 8 days. We feel [hacleuko[riene C, and 
D4 could play an importanr role in post-inflammatory mela-
nocy[e hyperplasia.] Invest Dwnatol93:719-722, 1989 
known naturally produced melanocyte mitogens are incapable of 
supporting melanocyte growth without the addition of other mito-
gens, it is likely that other naturally occurring compounds exist 
which also have stimui.amry effects on melanocyte growth. 
Arachidonic acid and its metabolites (eicosanoids}.are membrane-
derived compounds which have been implic2ted as mediators of 
many biological events, including the pathogenesis of inflamma-
tory dermatoses, such as psoriasis !6] and sunburn [7]. Leukotriene 
B" and leukotricne C 4 have been reported to be elev2ted in lesiona.l 
skin of psoriatic p2tients [8.9]. Furthermore. arachidonic 2cid. and 
several of the cyclooxygenase products, prostaglandin D2 , prosta-
glandin~, and prost2glandin F2a.lpba are increased following ultr.tvi-
olet irradi2tion 16]. Prost2glandin ~ and prosuglandin ~ also h2ve 
been shown to stimulace the proliferation of pigmenr cells in t.be 
pinn2! epidermis of the mouse 11 0]. Prosugl.andin D2 has been 
found to incre2se the siz.e 2nd dendricity of human mei2nocyres in 
culrure [II]. 
Post-infianm12tory hyperpigmentation follows sunburn 2nd 
many other inflamm2mry dcrmamses.lr consists of bath an increase 
in the total number of melanocytes as well as 2n increase in melanin 
production by individual mel2nocytes [12]. 
Therefore, given the potential diverse effects of eicoS2Iloids and 
the observed response of melanocytes to ultr2violet injury and in-
flanunacion. if is possible th2f this class of lipid substances, or spe-
cific members of the eicosanoid family. may be natural melanocyte 
growth factors produced during infla.mmation. In order to test this 
hypothesis we have developed an in vitro system to study the effects 
of eicosanoids on melanocyte growth . T his culrure system is devoid 
of aJl known mel2nocyrc growth factors except bovine pituitary 
extract which is present in our basal media (Keratinocyrc Growth 
Media). 
MATERIALS AND METHODS 
Human neonatal foreskin melanocytes were isolated according to a 
modified method of Eisinger 2nd Marko [1]. Melanocytes were 
initi211y grown in tissue culture flasks (Falcon 75 cm2, Deckton 
Dickinson Labware. Lincoln Park, NJ) in 2 5% CO2, 37°C humidi-
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f igure \. Time line detailing feeding and harvesting schedule for the ini-
rial expe.riments. Mel:mocytes were tranSferred from primary medium to 
KGM 011 day O. Cells were fed ex~rimental medium (x) 5 of every 7 d2Ys 
and harvested (0) on days 7,14.21, and 28. 
fied environment using Ham's FlO media with added NaHC02 
(1.2 gi L), HEPES (S.96 gi L), fetal calf serum (5% v/ v), chole ta 
toxin (2.5 nM), TPA (20 ng/ ml), IBMX (100 nM). calcium chlo-
ride (2.0 nM) , and penicillin/ strcptomycin/ fungizone. After reach-
ing the required number of cells necessary for an experitnent , the 
melanocytes were transferred to 6-well plates (Falcon). At this time, 
the media was changed to Keratinocyte Growth Media (Clonetics 
Inc., San Diego. CA) wbich consists of modified MCDB J 53 with 
added EGF (10 ng/ ml), insulin (5.0 I'g/ ml), hydrocortisone (0.5 
I'g/ ml). calcium chloride (0. 15 nIM), bovine pituitary extract (0.4% 
v/ v), and PIS/F. Forth. initial experiments, 100 nM PGD" PGE" 
LTB •• LTC •• LTD •• LTE •. and 1 )1M arachidonic acid, 1 : 1 in 
PBS/ rrhanol (Cayman Chemicals. Ann Arhor, MI), were added 
individually to the KGM (Fig 1). T he fInal concentratjon of ethanol 
was Ie-ss than ·10 mM. which is not toxic to these cells. T hese doses 
wert' chosen becau'.ic they correspond co the amounts of arach,don-
ate and prostaglandins found in suction blister fluid twenty-four 
hours following UVR irr:Jdi:uion [7l. Cells were fed eitber control 
or eicosanoid containing media five of seven days. T hus. eicosanoids 
were added with each media change (Fig 1). Cells were washed 
twice with phosphate-buffered sal ine pH 7.4 and harvested by tryp-
siui.zation (i rvine Scientific, Sama Ana, CA, 1 : 250. 1.5 ml/ well for 
5 min) on days seven, fourtee.n. twenty-one, ;md twe.nry-eight post 
transfer (Fig 1 A). Cells were counted using a Coul ter coumer (at-
tenuation 0.707, aperture 8). Dose response experiments were per-
formed using concentrations of 10, 30, toO, and 200 nM LTC .. . 
Experiments were performed in triplicate. individual donors were 
used for each scparate experiment. T hree to five experiments were 
done a1 each concentration of eicosanoid. 
To investigate whether the delay in rhe m.i togenic effeCt of L T C4 
might be due to residual effects of the mitogens present in tbe 
primary culture medium, melanocytes were nrst transferred to 
KGM for 14 days. The experiments were then carried out as pre-
viously discussed (Fig 2). 
To evaluate the ability of cultu red human meianocyres to merab-
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Figure 2. Time line detailing feeding and harvesring schedule for experi-
menrs in-vestigaring mitogen withdrawal. Melanocytes were transferred 
from primary medium to KGM on day O. Cells were fed KGM (k) on days 4, 
8, .and 12 and chen were fed expcrimenul medium (x) 5 of every 7 days 
beginning on day 15. Cells were harvested (0) on days 21 and 28. 
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Figure 3. Melanocyte cell number at seven. fourteen, twenty-one, ;md 
ev,'enty-c'ght days following the addition of 1)J.M arachidonic acid, 100 oM 
prosuglaudin Dol ' or 100 nM prosr~glandin Ez taconeral medium. Error bars 
represent the standard deviation of three separate experiments. 
tivity 20 - 60 Ci/ntM) (New England Nuclear) was added to mela-
nocyte cultures. Culture- media were collect<.>d at 0, 3, 9. and 24 h 
following addition of the radioactive LTC4 • As a control. tritiated 
L TC 4 was added ta culture media alane. incub;m~d at 37"C, and 
collected at twenry-four hours. Ethanol was added to the collected 
medja (0 a final concentratjon of 80% and precipita ted protein was 
removed by cenrrifugation. T he supernatant was evaporatcd under 
vacuum to dryness and the residue was dissolved in 2 mJ of a 30% 
methanol solur.ion. 
The resulting products were separated on a reverse-phase HPLC 
system (Beckman Model 420,Jones Apex 2 C 1B column). and the 
effluent monitored for elution of UV absorbing products with a 
djode array detector (Hewlett Packard 1040A). The initial H PLC 
mobile phase was 30% m~th.anol, 70% W3t(>r, 0.02% phosphoric 
acid. pH 5.7; this was held constant for 5 min. The mobile phase was 
then progressively increased to 100% methanol over rhe next 30 
min a.nd remained at 100% methanol for 10 rnin. One minute 
fractions were collected, mixed with scinrillation cocktail (Safety-
Solve, Research Products Internationa1 Corp., Mount Prospect, IL) , 
and counted on a scintillation counter. Radioactivity peaks were 
compared to the mjgration of known standards (Cayman Chemj-
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Figure of . Melanocyte cell number at seven, fourteen. twenty-one. and 
twenty-eight days following the- addition of 100 nM leukofri~e 8 4 , 100 nM 
leukotricne C. , Qr t OO nM leu kQtt;,ene E.. to control med.ium. Error bars 
n:present rh t': stand.ard deviatio n of three separate experiments, 
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f ig ure ~. Melanocyte cell number ;,at SC'vc n. founcen. rwcnry-one. ;;md 
twenty:(' ,ght days following the addition of J 00 nM leukotriene C 4 • 100 nM 
kukotrlene D •. or 100 nM leukotriene E. to control medium. Error bars 
represem tht' st:llndard deviation of three st'par.ue experiments. 
RESULTS 
Initial cxperhnems c:valuated the effect of 1 ,uM arachidonic acid. 
and tvm products of the cydooxygenase pathway. 100 nM PGD2 
and tOO nM PG~. There was no difference in growth rate bcrween 
control cul tures with or without these eicosanoids at any time dur-
ing rhe experiment (Fig 3). 
The e.ffect of l?O ~M L TB., LTC •• and L TE. on melanocyte 
growth IS shown III FTg 4. At seven days. there was no difference 
between coorrol cultu res and those stimulated with the Icuko-
trienes: A differencC' was fi.rst noted at fOllrteen days, with an in-
crease III number of melanocytes grown in culture with LTC •. This 
stimulation o( gtowth was increasingly evident at twe.nty-one and 
twenty-eigh t days in culture. There was no effect seen from either 
LTD, or LTE, (Fig 4). 
We nex t compared the effect of 100 nM LTC •. LTD •• and LTE" 
on melanocyte growrh (Fig 5). Again, no differences were nored at 
seven days between control cultures and those with added leuko-
tri cnes. As before, an increase was seen at 2 weeks in the number of 
tnelanocytes grown in the media supplemented with LTC •. and this 
growth differential became more marked with time. The growth of 
melanocytcs stimulated with LTD. was equivalent to the growth of 
melanocytes stimulated with LTC •. 
Since tOO nM LTC. increased the growth of cul tured mdano-
cytes, a full dosC'-response srudy of the LTC" stimulation of melano-
cyte growth was performed. As seen in Fig 6, no difference was 
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Figur~ 6. Dose-response' curves at seven. fourteen, twenty-one. and 
twenty-eight days to O. 1 D. 30. 100. and 200 nM LTC •. 
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Fi~~e 7. Melanocyte cdl num~r .11 seven and fourteen cLays following the 
addHlon of 100 nM LTC. to control l!1e'dium. Cells wen~ maimained in 
KGM for founecll cLays prior to ~ginning tht' ex~riment. Error bars rt'pre-
sent the su.ndard devl2uon of three separ.me experimen ts. 
noted III rhe first seven days at any dose of LTC" from 1 0 to 200 oM, 
bUi a difference in growth was noted at t 4 d and became more 
evident with rime. Enhanced growth of cultu red melanocytes to 
LTC. was clearly dose dependent within the r.:l.Oge tested (Fig 6). 
Significant enhanced growth was observed after 1 mo of exposure to 
30 nM LTC,_ 
When melanocytes were first transferred to KGM for 14 d before 
beginning the experiment (see protocol in Fig 2). a significant dif-
ference berween concrol cultures and those grown in LTC. was 
noted at one week (Fig 7). 
Cultured mclanocytes were a1so exposed to (lH]-labcled LTC. to 
study the rime course of LTC. metabolism. Within the first 3 h of 
incubation melanocytes were found to convert 60% of the injtial 
L T C 4 into L TE4 (Fig 8). No intermediate fortrurion of a LTD.-l ike 
product was noted. Also no further metabolism of the LTE.-like 
product occurred (Fig 9), although only 7. 0% of the initial [lH 1-
LTC. waS recovered. In control experiments the recovery of PH -
LTC. following the extraction and HPLC sepa.rarion was found to 
be 60%-80%. 
DISCUSSION 
T~lIs study has demonstrated that LTC. and LTD. can be potent 
snmulams of melanocyte growth in cul ture with significant effects 
observed in culture by chronic exposure to 30 oM LTC., while AA 
at 1 JlM. and PGD2• PGE2 , L TB •. and LTE. at 100 nM do nO[ 
stimulate melanocyte growth. The popu.lation doubling time for 
melanocytcs grown with 100 11M LTC. and LTD. is berween 5 and 
8 days, w:lich is comparable to tbe population doubling time ob-
tained in our laboratory using medium containing O-tetradecan-
oylphorboI 13-acetate (20 ng/ ml), cholera toxin (2.5 nM), ;sobu-
rylmcthylxanrhine (100 nM), and fe tal ca lf serum (5% v/ v). 
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F~gure 8. Percenr o.f totaJ radioactivity <:o- migrating with srantbrd leuko-
tr~e.l1(, C. or leu.kotrlene ~ at O. 3. 9, ;,and 24 II following the addirion of 
trltlatt'd Icukotrl~n~ C 4 to cuirurrd human meb.nocyres . .Error bars represcnt 
tht' st:lnd;ard devlarloll of rh ree separate experiments. 










Figure 9 . HPLC rr:lcingof mdanoc),U' supernatant collected 3 h following 
the addition oflH.Lt'ukorriene C. ( 0 cultured human neo natal 111e1 anocytes. 
Th~ fK'aks:1f 5. 24. and 29 m in corr~spond to the solvenl front . leukotriene 
C •. :Iond lcukotrienc E •. respectively. 
Melanocytes respond to LTC. in a dose-dependent fashion with an 
even shoner population doubling time at a LTC. concentracion of 
200 nM. 
IniTially. the growTh differential berv.·een mdanocytes grown in 
control media and those grown with the addition of LTC. and 
LTD. was nOt noted until the second week of each experiment. and 
the differential increased with each succeeding week. When mela· 
nocytes were first transferrc::d to KGM for rwo weeks before the 
addition of The eicosanoids. the growth differential was significant 
at one week. W e presume the delay in growth differential in our 
6rsr series of experiments was due to the fact that our initial culture 
SYSTem contains many mirogens and [hat the mitogenic effect of 
these stin1ulants. especially TPA. may last up to two ",'ceks. Tbere· 
fore, experiments evaluating human melanocyte micogens in cul-
ture systems which have contained TPA may require moce than one 
week to identify differences. 
When tritiated LTC .. is added to melanocyte cultures, it was 
found to be rapidly metabolized with iD three hours to a product 
with the HPLC retention time of LTE .. . No furt·her metabolism of 
this compound was noted up to twe.nty-four hours. L TE. when 
added to our cultures at 100 nM was not capable of stimulating 
melanocy te growth . It is qui te poss ible the metabolism of LTC .. to 
L Tf~ is linked in some way to the mitogenic properties of LTC ... 
T he m.echanism of aerion of LTC .. is unknown at this rime. but 
sulfidopeptide leukotrienes are known [0 bind (0 cell surface recep· 
tors and stimulate the breakdown of PI [0 diacylglycerol and IP, 
{1 3]'lt is also possible that this effect may be mediated through an 
increase in intracel lular cAMP or by stimulating the melanocytes to 
produce peptide growth factors. No intermediate formation of 
LTD~ was noted. but it is likely that the action of gammagluramyl 
rranspeptidase. and dipeptidase arc quite rapid. The effect of LTD~ 
on melanocyte growth is equivalent to that of LTC .. and this effect 
may also be related to receptor binding and subsequent metabolism 
co L TE~. Evidence for LTC. and/ or LTD .. binding sites on melano-
cyte membranes is under investigation. 
LTC~ and LTD. are known to be present in increased amounts in 
psoriasis and other inflarrunatory dermatoses PJ. Arachidonic acid. 
PG 0:1:0 and PG~ have been reported to be e!C'vated 24 h following 
UV irradiation r6j, but an increase in LTC4 or LTD .. following UV 
irradiation has not been measured. Pros taglandins do not account 
torally for the erythema following UV irradiation and do not stimu-
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late melanocyte growth in our system. h is possib le that LTC .. 
and/oT LTD. are produced following UV irradiation and that they 
:lre a major signal for post-inflammatory melanoc)' t(' hyperplasia. 
Many cells are known to contain the e.m.ymes necessary to per-
form sulfidopeptide leukotriene synthesis which include 5-l ipmry-
genase to synthesize the reaction inrcnnediare L TA. and LTC. 
synthetase. a specific glutathione transferase which conjugates glu. 
tathione to LTA4 to yield LTC~ , Cells which have the complete 
apparatus incl ude the mast ce ll , basophil. eosinophil, and macro-
phage. In addition. rranscellular biosynthesis of LTC. can result 
from the acrivation of the neutrophil to synthesize L TA~. which can 
be transferred to an acceptor cell containing glutathione and LTC. 
synthetase . Acceptor cells include endothel ial cel ls and platelets 
1141. 
T hus, we have demonstrated tbar of the eicosanoids tested in our 
system. only L TC~ and L TD4 are capable of stimulating melanocyte 
growth. KGM may not be an optimal medium for melanocyte 
growth. but when LTC .. or LTD .. are added this medium ca.n sup-
port tht" long·tenn growrh of mdanocytes. LTC. and L TD~ are 
naturally produced mitogcns and under some ci rcumstances may be 
important in vivo signals for melanocyte proliferation. 
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